-
公开(公告)号:US5733884A
公开(公告)日:1998-03-31
申请号:US554475
申请日:1995-11-07
申请人: Adrian Barbul , Lisa Stewart Bebenek , David A. Mark , Susan Trimbo , Diana Twyman , Paul Lin
发明人: Adrian Barbul , Lisa Stewart Bebenek , David A. Mark , Susan Trimbo , Diana Twyman , Paul Lin
CPC分类号: A23G3/368 , A23L33/12 , A23L33/15 , A23L33/40 , A61K38/01 , A23V2002/00 , Y10S514/943
摘要: The present invention provides an enteral nutritional formulation that meets the nutrient requirements of patients with wounds. The present invention meets the unique nutrient needs of the acute or chronic patient that are generated due to tissue repair and healing requirements of wounds. To this end, in an embodiment, the present invention provides a method for providing nutritional support to a patient with an acute or chronic wound comprising the step of administering a therapeutically effective amount of composition comprising a protein source including an arginine source and a proline source in the ratio by weight of approximately 1:0.5 to about 4:1. The composition may also include a carbohydrate source, a lipid source including an appropriate n6:n3 ratio, and at least the U.S. RDA for vitamins and minerals provided in an amount of formula supplying 1000 kcal, with vitamin A, beta-carotene, vitamin C, vitamin E, thiamine, pyridoxine, biotin and zinc being supplied in amounts above the U.S. RDAs.
摘要翻译: 本发明提供了能够满足伤口患者营养需求的肠内营养制剂。 本发明满足由于组织修复和伤口愈合要求而产生的急性或慢性患者的独特的营养需求。 为此,在一个实施方案中,本发明提供了一种用于向患有急性或慢性伤口的患者提供营养支持的方法,包括施用治疗有效量的组合物的步骤,所述组合物包含蛋白质源,所述蛋白源包括精氨酸源和脯氨酸来源 重量比为约1:0.5至约4:1。 组合物还可以包括碳水化合物源,包括适当的n6:n3比例的脂质源,至少提供以供给1000千卡的配方的维生素和矿物质的美国RDA,维生素A,β-胡萝卜素,维生素C ,维生素E,硫胺素,吡哆醇,生物素和锌的供应量高于美国RDAs。
-
公开(公告)号:US5576351A
公开(公告)日:1996-11-19
申请号:US341443
申请日:1994-11-16
申请人: Norman N. Yoshimura , Adrian Barbul , Robert C. Tao , Michael C. Storm , Robert E. Kelley , Brenda L. Reis
发明人: Norman N. Yoshimura , Adrian Barbul , Robert C. Tao , Michael C. Storm , Robert E. Kelley , Brenda L. Reis
IPC分类号: A23L1/29 , A23L1/305 , A61K31/195 , A61K31/19
CPC分类号: A61K31/195 , A23L33/175 , A23L33/40 , Y10S514/885
摘要: The present invention relates to the treatment of an impaired human immune response or to reduction of the severity of degradation of the human immune response by the administration of arginine or ornithine, or a functional analog of arginine or ornithine, or mixtures thereof, to humans suffering from an impaired immune response or at risk of suffering an impaired immune response. Such treatment is provided by enterally administering compositions supplemented with arginine or ornithine, or functional analogs of arginine or ornithine, or parenterally administering amino acid solutions supplemented with arginine or ornithine, or functional analogs of arginine or ornithine, to the patient.
摘要翻译: 本发明涉及通过将精氨酸或鸟氨酸或精氨酸或鸟氨酸或其混合物的功能类似物或其混合物施用于患有人的人类免疫应答或降低人免疫应答降解的严重性 来自受损的免疫应答或受到免疫应答受损的风险。 这种治疗通过肠内施用补充有精氨酸或鸟氨酸的组合物,或精氨酸或鸟氨酸的功能类似物,或肠胃外给予补充有精氨酸或鸟氨酸的氨基酸溶液或精氨酸或鸟氨酸的功能类似物给予患者来提供。
-
公开(公告)号:US5157022A
公开(公告)日:1992-10-20
申请号:US440589
申请日:1989-11-22
申请人: Adrian Barbul
发明人: Adrian Barbul
IPC分类号: A61K31/195 , A61K31/198 , A61K31/44 , A61K38/00 , A61K38/04 , A61P3/06 , A61P9/10
CPC分类号: A61K38/04 , A61K31/195
摘要: A method for reducing the level of cholesterol in the bloodstream of a human being in provided. The method comprises the administration to a human or arginine derivative compound, or a related amino acid or derivative. Daily doses of these compounds have been found to significantly reduce blood cholesterol level.
摘要翻译: 一种降低人血液中胆固醇水平的方法。 该方法包括给予人或精氨酸衍生物化合物或相关氨基酸或衍生物。 已经发现这些化合物的日剂量显着降低血液胆固醇水平。
-
-